List of Ipca Laboratories patents

List of Ipca Laboratories patents

List of Sintokogio patents

List of Severin Elektro patents

List of Trifacta patents

List of SBIR/STTR awards granted to Texas Research Institute, Austin, Inc.

List of FounderFuel 2019 companies

Patents where

Current Assignee

Name

is

Ipca Laboratories

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7459467 Manufacturing process for methyl phenidate and intermediates thereof	Patent 7459467 was granted and assigned to Ipca Laboratories on December, 2008 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7459467	December 2, 2008
	‌ US Patent 9492406 Pharmaceutical composition	Patent 9492406 was granted and assigned to Ipca Laboratories on November, 2016 by the United States Patent and Trademark Office.	Ipca Laboratories	Ipca Laboratories		United States Patent and Trademark Office	9492406	November 15, 2016
	‌ US Patent 7414151 Process for manufacture of 4-amino-hydroxybutylidene-1, 1-bisphosphonic acid and its salts	Patent 7414151 was granted and assigned to Ipca Laboratories on August, 2008 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7414151	August 19, 2008
	‌ US Patent 7345071 Process for the synthesis of Losartan potassium	Patent 7345071 was granted and assigned to Ipca Laboratories on March, 2008 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7345071	March 18, 2008
	‌ US Patent 7847127 Process for preparation of atovaquone and novel intermediates thereof	Patent 7847127 was granted and assigned to Ipca Laboratories on December, 2010 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7847127	December 7, 2010
	‌ US Patent 7847094 Industrial preparation of 11-[4-{2-(2-hydroxyethoxy) ethyl}-1-piperazinyl] dibenzo [b,f]-[1,4]thiazepine	Patent 7847094 was granted and assigned to Ipca Laboratories on December, 2010 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7847094	December 7, 2010
	‌ US Patent 10105353 Anti-thrombotic compounds	Patent 10105353 was granted and assigned to Ipca Laboratories on October, 2018 by the United States Patent and Trademark Office.	Ipca Laboratories	Ipca Laboratories		United States Patent and Trademark Office	10105353	October 23, 2018
	‌ US Patent 7763748 Process for preparation of highly pure isotretinoin	Patent 7763748 was granted and assigned to Ipca Laboratories on July, 2010 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7763748	July 27, 2010
	‌ US Patent 9321785 Methods for the treatment or prophylaxis of thrombosis or embolism	Patent 9321785 was granted and assigned to Ipca Laboratories on April, 2016 by the United States Patent and Trademark Office.	Ipca Laboratories	Ipca Laboratories		United States Patent and Trademark Office	9321785	April 26, 2016
	‌ US Patent 7547791 One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O	Patent 7547791 was granted and assigned to Ipca Laboratories on June, 2009 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7547791	June 16, 2009
	‌ US Patent 7629465 Industrial process for preparation of Clopidogrel hydrogen sulphate	Patent 7629465 was granted and assigned to Ipca Laboratories on December, 2009 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7629465	December 8, 2009
	‌ US Patent 7615571 Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt	Patent 7615571 was granted and assigned to Ipca Laboratories on November, 2009 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	7615571	November 10, 2009
	‌ US Patent 8415360 Pharmaceutical compositions for the treatment of diabetes mellitus	Patent 8415360 was granted and assigned to Ipca Laboratories on April, 2013 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	8415360	April 9, 2013
	‌ US Patent 8541422 Methods for the treatment or prophylaxis of thrombosis or embolism			Ipca Laboratories		United States Patent and Trademark Office	8541422	September 24, 2013
	‌ US Patent 8536337 Solid forms of methyl (7aS,2′S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate			Ipca Laboratories		United States Patent and Trademark Office	8536337	September 17, 2013
	‌ US Patent 6916935 Losartan potassium synthesis	Patent 6916935 was granted and assigned to Ipca Laboratories on July, 2005 by the United States Patent and Trademark Office.		Ipca Laboratories		United States Patent and Trademark Office	6916935	July 12, 2005

16 results

0 selected

16 results

0 selected